M&A Deal Summary

BioNTech Acquires InstaDeep

On January 10, 2023, BioNTech acquired software company InstaDeep from Africinvest for 362M GBP

Acquisition Highlights
  • This is BioNTech’s 1st transaction in the Software sector.
  • This is BioNTech’s largest (disclosed) transaction.
  • This is BioNTech’s 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2023-01-10
Target InstaDeep
Sector Software
Buyer(s) BioNTech
Sellers(s) Africinvest
Deal Type Add-on Acquisition
Deal Value 362M GBP

Target

InstaDeep

London, United Kingdom
website
InstaDeep is an Artificial Intelligence company that makes use of AI to help businesses make complex decisions, better design their products and solve problems that are not easily solved with traditional approaches. InstaDeep was founded in 2014 and is based in London, United Kingdom.

Search 193,103 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

BioNTech

Mainz, Germany

website

Category Company
Founded 2008
Sector Life Science
Employees2,500
Revenue 17.3B EUR (2022)
DESCRIPTION

BioNTech is Europe’s largest privately held biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. The Company combines all building blocks of individualized immunotherapy under one roof – from diagnostics and drug development to manufacturing. Its cutting-edge technologies range from individualized mRNA-based medicines through innovative chimeric antigen receptors and T-cell receptor-based products to novel checkpoint immunomodulators. BioNTech founded in 2008 and is based in Mainz, Germany.

DEAL STATS #
Overall 4 of 4
Sector (Software) 1 of 1
Type (Add-on Acquisition) 2 of 2
Country (United Kingdom) 1 of 1
Year (2023) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-19 Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility

Gaithersburg, Maryland, United States

Kite Pharma's Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility provides production capacity to support clinical trials.

Buy -

Seller(S) 1

SELLER

Africinvest

Tunis, Tunisia

Investor Investor Investor Investor Investor

website

Category Growth Capital Firm
Founded 1994
PE ASSETS 1.9B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Africinvest is a private equity firm focused on growth investments in African companies. The Firm generally targets minority investments in small to medium-sized companies, but Africinvest will consider select majority situations. Africinvest does not have any sector preferences and looks to hold for 4 to 6 years. Africinvest was formed in 1994 and is headquartered in Tunis, Tunisia.

DEAL STATS #
Overall 10 of 12
Sector (Software) 1 of 1
Type (Add-on Acquisition) 5 of 5
Country (United Kingdom) 1 of 1
Year (2023) 1 of 3
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-27 Bridge Bank

Cote d'Ivoire, South Africa

Bridge Bank is a holding company which has a majority equity stake in Bride Bank Cote d’Ivoire , an Ivorian universal Bank and a minority significant equity stake in a bank in Senegal. Bridge Bank is based in Cote d'Ivoire, South Africa.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-17 Afitexinov

Champhol, France

Afitexinov produces and markets geosynthetic materials for the construction, public works, environment and mining sectors. Afitexinov is based in Champhol, France.

Sell -
Mergr

Product

Company

Legal